FDA monitoring popular weight loss drugs for side effects
Newsy
Users of popular weight loss drugs have reported suicidal ideation, hair loss and aspiration, prompting an FDA investigation.
The Food and Drug Administration released a report indicating it is investigating several reports of possible side effects involving popular weight loss drugs. The risks include suicidal ideation, hair loss and aspiration (the act of having food or drinks go down the wrong tube).
The FDA's Adverse Event Reporting System report included popular drugs such as Mounjaro, Ozempic, Trulicity, Victoza and Wegovy. A full list of drugs and their potential side effects is available on the FDA's website.
The FDA said it is "evaluating the need for regulatory action." Health care professionals, consumers, and manufacturers are able to submit reports to the FDA to consider the adverse effects of drugs.
The FDA says just because a drug is on the report does not mean that the drug caused the reaction in question.
"While consumers and health care professionals are encouraged to report adverse events, the reaction may have been related to the underlying disease being treated, or caused by some other drug being taken concurrently, or occurred for other reasons. The information in these reports reflects only the reporter's observations and opinions," the FDA said.
